Skip to content

Safety & efficacy of Zandu Chyawanprash in general debility & weak immunity

Evaluation of the safety & efficacy of Zandu Chyawanprash debility & symptoms associated with weak immunity - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077617
Enrollment
50
Registered
2024-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Emami Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subject having any three symptoms among Kasa (Cough), Svarabheda (Hoarseness of voice), Agnimandya (Digestive impairment), Smritidaurbalya (Cognitive issues), Daurbaly (Weak strength, stamina & low energy), Kshin Anamaya (Weak immunity – Frequent illness such as common cold, body ache), Apraharsh (decreased vigour) Age- 18 years- 65 Years of either sex Co-operative and fully conscious

Exclusion criteria

Exclusion criteria: Diabetes mellitus, Severe bronchial Asthma /COPD, Any symptomatic cardiac disease, Chronic debilitating conditions like hepatic/ renal insufficiency Carcinogenic condition (Confirmed through history/clinical examination), Any acute illness/ serious illness, Fever/ delirium, hypertension, Known hypersensitivity or allergy to one or more of the herbal ingredients, Recent (less than 1 month) participation in a clinical trial, Recent (less than 1 month) use of any Herbal/Ayurvedic drugs, Other debilitating neurological or psychiatric disorders, Any condition likely to hinder the compliance with the protocol

Design outcomes

Primary

MeasureTime frame
Kasa - Cough symptom score Agnimandya - Severity of the symptoms of indigestion on the basis of Likert scale Smritidaurbalya – Verbal recall Daurbalyata - Visual Analouge Scale score Kshin Anamay (Weak immunity) – History of frequent illness Stress & Anxiety – Hamilton anxiety rating scale Timepoint: Day 0, Day 30, Day 60, Day 75

Secondary

MeasureTime frame
Hemoglobin, TLC, DLC, ESR, SGPT, SGOT, Urea, Creatinine, FBSTimepoint: Day 0, Day 30, Day 60

Countries

India

Contacts

Public ContactProf Radha Ballabh Sati

Uttarakhand Ayurved University, Faculty of Ayurveda, Main Campus, OPD no. 11

drsatirb@gmail.com8077747461

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026